European Archives - Page 930 of 1157 - European Medical Journal

European Medical Journal 2.3 2017

Welcome to this year’s third instalment of the European Medical Journal. The issue contains an abundance of high-quality, peer-reviewed articles…

How I Manage Myelofibrosis

Myelofibrosis (MF), either primary or secondary to polycythaemia vera or essential thrombocythaemia, is the most symptomatic and has the worst prognosis…

How I Diagnose Hypereosinophilic Syndromes

Hypereosinophilic syndromes are a group of disorders characterised by significant eosinophilia and organ damage.

Management of Multiply Relapsed Aggressive Non-Hodgkin Lymphoma: New Perspectives

Patients with refractory/relapsed (R/R) non-Hodgkin lymphoma (NHL) make up a very heterogeneous population with a poor life expectancy.

Redefining Later-Line Therapy in Metastatic Colorectal Cancer

The objective of the symposium was to provide an overview of the current treatment landscape in terms of later-line therapy in metastatic CRC (mCRC) and to discuss the evidence for the various options available.

Management of B-Cell Lymphoma: Where Are We Now and Where Are We Going?

The main objectives of the symposium were to explore the current developments in the diagnosis and treatment of non-Hodgkin lymphoma (NHL).

Editor’s Pick: Renal Involvement in Multiple Myeloma

Multiple myeloma (MM) is a plasma cell disorder that represents almost 10% of haematologic malignancies.

Treatment Options in Cardiogenic Shock with Intra-Aortic Balloon Counterpulsation

Cardiogenic shock (CS), a state of inadequate tissue perfusion due to cardiac dysfunction, remains the leading cause of death following acute myocardial…

Peyronie’s Disease: Recent Treatment Modalities

Peyronie’s disease (PD), which is characterised by fibrous plaque formation in the tunica albuginea of the penis, is associated with pain, erectile…

Significance of Asymptomatic Bacteriuria

Since the recognition of asymptomatic bacteriuria (ABU), several studies have questioned its significance.